Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on April 22, 2026

Apr. 22, 2026

SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Ligand to Report First Quarter 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program

Indeterminate GlobeNewswire

Apr. 22, 2026

Grey Matters Announces Private Placement

Indeterminate GlobeNewswire

Apr. 22, 2026

NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs

Indeterminate GlobeNewswire

Apr. 22, 2026

BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs

Indeterminate GlobeNewswire

Apr. 22, 2026

SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156

Indeterminate GlobeNewswire

Apr. 22, 2026

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value

Indeterminate GlobeNewswire

Apr. 22, 2026

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Indeterminate GlobeNewswire

Apr. 22, 2026

EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Apr. 22, 2026

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

Blue Mountain Acquires CompuCal to Expand European Presence and Deepen Calibration Expertise

Indeterminate GlobeNewswire

Apr. 22, 2026

Blue Mountain übernimmt CompuCal, um seine Präsenz in Europa weiter auszubauen und seine Kalibrierungskompetenz gezielt zu stärken

Indeterminate GlobeNewswire

Apr. 22, 2026

Blue Mountain acquiert CompuCal pour renforcer sa présence européenne et son expertise en étalonnage

Indeterminate GlobeNewswire

Apr. 22, 2026

Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance

Indeterminate GlobeNewswire

Apr. 22, 2026

AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder

Indeterminate GlobeNewswire

Apr. 22, 2026

Medicines360 and Pharma Dynamics announce the launch of Avibela® in South Africa, Expanding Access to Long‑Acting Contraception and Treatment of Heavy Menstrual Bleeding

Indeterminate GlobeNewswire

Apr. 22, 2026

Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting

Indeterminate GlobeNewswire

Apr. 22, 2026

Elkedonia strengthens Board of Directors with appointment of Pierre d’Epenoux as Independent Chairman

Indeterminate GlobeNewswire